Amniotic Membrane Augmentation for Enucleation After Chemotherapy in Retinoblastoma

Aparna Ramasubramanian,Nisha S. Rehman,Argudit Chauhan,Aurora Rodriguez,Amy Leverant,Nishant Tiwari
DOI: https://doi.org/10.3928/01913913-20240307-01
IF: 1.33
2024-04-25
Journal of Pediatric Ophthalmology & Strabismus
Abstract:Purpose: To describe amniotic membrane augmentation for enucleation after chemotherapy in retinoblastoma. Methods: This was a retrospective study of patients with retinoblastoma who underwent enucleation. The study also evaluated the utility of amniotic membrane grafting in enucleation after chemotherapy in eyes with retinoblastoma. Results: In this study, 110 eyes of 107 patients were analyzed, and 49 patients had previous systemic chemotherapy, 13 eyes had previous intra-arterial chemotherapy, and 7 eyes had external beam radiation. Amniotic graft was used in 8 eyes (5 following IAC, 2 following systemic chemotherapy, and 1 after both). After IAC, 3 of 7 eyes without amniotic graft had implant exposure compared to 0 of 6 eyes with amniotic graft ( P = .05). Pathological examination of the conjunctiva after intra-arterial chemotherapy showed goblet cell hypoplasia that hinders wound healing. Conclusions: Amniotic membrane augmentation improves wound integrity in patients with retinoblastoma, especially following intra-arterial chemotherapy. [ J Pediatr Ophthalmol Strabismus . 20XX;X(X):XXX–XXX.]
pediatrics,ophthalmology
What problem does this paper attempt to address?